The Taiho and Eli Lilly-backed immunotherapy developer floated in the middle of its range to raise $75.6m, valuing it at about $334m.

Nan Fung-backed biopharmaceutical company Stealth Bio has filed for an IPO that could bring in almost $87m if it floats at the top of the range.

Cox Enterprises, Groupe Arnault and Novel have achieved an exit as location analytics platform Euclid was acquired by WeWork for an undisclosed sum.

HouseMyDog has merged with fellow dog walking and sitting service provider Gudog, which counts Wayra among its investors.

The streaming platform has expanded its podcast content with the purchase of GV-backed Anchor, just days after buying Gimlet Media for more than $200m.

The AbbVie, Eli Lilly, Amgen, Merck & Co and Alphabet-backed neurodegenerative disease drug developer is floating in the middle of its range.

Slack has confidentially filed for a direct listing that will allow SoftBank Vision Fund, Comcast Ventures and Alphabet unit GV to sell shares.

6 Dimensions Capital is set to exit immuno-oncology drug developer TCR² Therapeutics in an offering likely to raise between $70m and $80m.

VetMedUni biopharmaceutical spinout Marinomed Biotech has completed its IPO to attain a market cap of $109m.

The streaming platform is in advanced talks to acquire podcast producer Gimlet Media, which has raised $27m from investors including WPP and Graham Holdings, for more than $200m.